{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:35:15Z","timestamp":1761100515014},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2002,2,1]]},"DOI":"10.1038\/sj.bmt.1703296","type":"journal-article","created":{"date-parts":[[2002,9,5]],"date-time":"2002-09-05T18:19:43Z","timestamp":1031249983000},"page":"S10-S13","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Rituximab: enhancing stem cell transplantation in mantle cell lymphoma"],"prefix":"10.1038","volume":"29","author":[{"given":"AM","family":"Gianni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Cortelazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Magni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Martelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the Michelangelo Cooperative","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2002,2,12]]},"reference":[{"key":"BF1703296_CR1","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","volume":"84","author":"NL Harris","year":"1994","unstructured":"Harris NL, Jaffe ES, Stein H et al. A revised European\u2013American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group Blood 1994 84: 1361 1392","journal-title":"Blood"},{"key":"BF1703296_CR2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1046\/j.1365-2559.2000.00895.x","volume":"36","author":"NL Harris","year":"2000","unstructured":"Harris NL, Jaffe ES, Diebold J et al. The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997 Histopathology 2000 36: 69 86","journal-title":"Histopathology"},{"key":"BF1703296_CR3","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1182\/blood.V83.7.1871.1871","volume":"83","author":"R Rimokh","year":"1994","unstructured":"Rimokh R, Berger F, Delsol G et al. Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomas Blood 1994 83: 1871 1875","journal-title":"Blood"},{"key":"BF1703296_CR4","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1182\/blood.V86.7.2715.2715","volume":"86","author":"CJ de Boer","year":"1995","unstructured":"de Boer CJ, Schuuring E, Dreef E et al. Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma Blood 1995 86: 2715 2723","journal-title":"Blood"},{"key":"BF1703296_CR5","first-page":"3","volume":"6","author":"O Press","year":"1996","unstructured":"Press O, Grogan T, Fisher R . Evaluation and management of mantle cell lymphoma Adv Leuk Lymph 1996 6: 3","journal-title":"Adv Leuk Lymph"},{"key":"BF1703296_CR6","doi-asserted-by":"crossref","first-page":"674a","DOI":"10.1182\/blood.V88.11.4085.bloodjournal88114085","volume":"88","author":"W Hiddemann","year":"1996","unstructured":"Hiddemann W, Brittinger G, Tiemann M et al. Clinical characteristics and response to chemotherapy of mantle cell lymphomas \u2013 results of a European survey Blood 1996 88: 674a","journal-title":"Blood"},{"key":"BF1703296_CR7","first-page":"1975","volume":"10","author":"R Haas","year":"1996","unstructured":"Haas R, Brittinger G, Meusers P et al. Myeloablative therapy with blood stem cell transplantation is effective in mantle cell lymphoma Leukemia 1996 10: 1975 1979","journal-title":"Leukemia"},{"key":"BF1703296_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/sj.bmt.1701046","volume":"21","author":"JY Blay","year":"1998","unstructured":"Blay JY, Sebban C, Surbiguet C et al. High-dose chemotherapy with hematopoietic stem cell transplantation in patients with mantle cell or diffuse centrocytic non-Hodgkin's lymphomas: a single center experience on 18 patients Bone Marrow Transplant 1998 21: 51 54","journal-title":"Bone Marrow Transplant"},{"key":"BF1703296_CR9","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1200\/JCO.1998.16.12.3803","volume":"16","author":"IF Khouri","year":"1998","unstructured":"Khouri IF, Romaguera J, Kantarjian H et al. Hyper-CVAD and high-dose methotrexate\/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma J Clin Oncol 1998 16: 3803 3809","journal-title":"J Clin Oncol"},{"key":"BF1703296_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1200\/JCO.1998.16.1.13","volume":"16","author":"AS Freedman","year":"1998","unstructured":"Freedman AS, Neuberg D, Gribben JG et al. High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission J Clin Oncol 1998 16: 13 18","journal-title":"J Clin Oncol"},{"key":"BF1703296_CR11","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1182\/blood.V90.10.4212","volume":"90","author":"NS Andersen","year":"1997","unstructured":"Andersen NS, Donovan JW, Borus JS et al. Failure of immunologic purging in mantle cell lymphoma assessed by polymerase chain reaction detection of minimal residual disease Blood 1997 90: 4212 4221","journal-title":"Blood"},{"key":"BF1703296_CR12","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1038\/sj.leu.2401488","volume":"13","author":"C Tarella","year":"1999","unstructured":"Tarella C, Corradini P, Astolfi M et al. Negative immunomagnetic ex vivo purging combined with high-dose chemotherapy with peripheral blood progenitor cell autograft in follicular lymphoma patients: evidence for long-term clinical and molecular remissions Leukemia 1999 13: 1456 1462","journal-title":"Leukemia"},{"key":"BF1703296_CR13","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1182\/blood.V89.2.724","volume":"89","author":"P Corradini","year":"1997","unstructured":"Corradini P, Astolfi M, Cherasco C et al. Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkin's lymphomas treated with high-dose chemotherapy and peripheral blood progenitor cell autografting Blood 1997 89: 724 731","journal-title":"Blood"},{"key":"BF1703296_CR14","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1182\/blood.V96.3.864","volume":"96","author":"M Magni","year":"2000","unstructured":"Magni M, Di Nicola M, Devizzi L et al. Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusion Blood 2000 96: 864 869","journal-title":"Blood"},{"key":"BF1703296_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/annonc\/6.suppl_4.S3","volume":"6 (Suppl.\u20094)","author":"C Tarella","year":"1995","unstructured":"Tarella C, Gavarotti P, Caracciolo D et al. Haematological support of high-dose sequential chemotherapy: clinical evidence for reduction of toxicity and high response rates in poor risk lymphomas Ann Oncol 1995 6 (Suppl.\u20094): 3 8","journal-title":"Ann Oncol"},{"key":"BF1703296_CR16","first-page":"115","volume":"5 (Suppl.\u200914)","author":"R Buckstein","year":"1999","unstructured":"Buckstein R, Imrie K, Spaner D et al. Stem cell function and engraftment is not affected by \u2018in vivo purging\u2019 with rituximab for autologous stem cell treatment for patients with low-grade non-Hodgkin's lymphoma Semin Oncol 1999 5 (Suppl.\u200914): 115 122","journal-title":"Semin Oncol"},{"key":"BF1703296_CR17","first-page":"141a","volume":"94 (Suppl.\u20091)","author":"SL Goldberg","year":"1999","unstructured":"Goldberg SL, Pecora AL, Jennis AA et al. Rituximab permits in-vivo purging and collection of tumor-free stem cells prior to autologous transplantation for B-cell non-Hodgkin's lymphoma Blood 1999 94 (Suppl.\u20091): 141a","journal-title":"Blood"},{"key":"BF1703296_CR18","first-page":"141a","volume":"94 (Suppl.\u20091)","author":"G Salles","year":"1999","unstructured":"Salles G, Moullet I, Charlot C et al. In vivo purging with rituximab before autologous peripheral blood progenitor cell (PBPC) transplantation in lymphoma patients (pts) Blood 1999 94 (Suppl.\u20091): 141a","journal-title":"Blood"},{"key":"BF1703296_CR19","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1046\/j.1365-2141.2000.02084.x","volume":"109","author":"MT Voso","year":"2000","unstructured":"Voso MT, Pantel G, Weis M et al. In vivo depletion of B cells using a combination of high-dose cytosine arabinoside\/mitoxantrone and rituximab for autografting in patients with non-Hodgkin's lymphoma Br J Haematol 2000 109: 729 735","journal-title":"Br J Haematol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1703296","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703296.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703296.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T22:34:43Z","timestamp":1648074883000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1703296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2,1]]},"references-count":19,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2002,2,1]]}},"alternative-id":["BF1703296"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1703296","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"type":"print","value":"0268-3369"},{"type":"electronic","value":"1476-5365"}],"subject":[],"published":{"date-parts":[[2002,2,1]]},"assertion":[{"value":"12 February 2002","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}